GVHIB News Alert Global Vision Holdings Inc. Cl B (GVHIB) 0.0017

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Global Vision Holdings Inc. Cl B (GVHIB) 0.0017 $GVHIB

Global Vision Holdings Inc. Reports Growth for Subsidiary: The Place Media
ACCESSWIRE - Wed Jul 30, 12:50PM CDT
IRVINE, CA / ACCESSWIRE / July 30, 2014 / Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.

Global Vision Holdings Inc. (OTCQB: GVHIB) is a Diversified Financial Holding Company Focusing on Investments in Environmentally Responsible, Profitable and Growing Companies
ACCESSWIRE - Thu Jul 24, 6:58PM CDT
IRVINE, CA / ACCESSWIRE / July 24, 2014 / Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.

Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.
eTeligis - Thu Jul 24, 6:50PM CDT
IRVINE, CA, United States, via eTeligis Inc., 07/24/2014 - - Mama's Best, a subsidiary of Global Vision, produces high quality organic sauces, marinades, soups, and spreads. After the incredible response of rolling out Mama's Best jams to Sprouts and Whole Foods, the consumer response exploded. This has lead Mama's Best into a new research and development stage of their company. The company is focusing on 5-10 new products such as five soups, two chimichurri sauces, four salad dressings and additional products. Glen Carnes, CEO and Chairman of Global Vision Holdings, Inc., which owns Mamma's Best, states "I am enthusiastic to roll out more of Mama's Best Products to it's consumers. We value the loyalty of our customer base and I look forward to sharing our products with the shopper."

PharmaPoint Report: Hemophilia A and B - US Drug Forecast and Market Analysis to 2022
M2 - Tue Feb 04, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/jvp3hs/pharmapoint) has announced the addition of the "PharmaPoint: Hemophilia A and B - US Drug Forecast and Market Analysis to 2022" report to their offering. The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden. The US is the largest hemophilia market, due to the high rates of disease diagnosis combined with high rates of primary rFVIII and rFIX prophylaxis among diagnosed severe hemophilia A and B patients. Companies such as Baxter, Bayer, Novo Nordisk, CSL Behring and Biogen Idec will be able to command slight premiums over currently marketed recombinant standard of care therapies, thus contributing to overall market growth. Scope - Overview of Hemophilia A and B including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. - Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis. - Sales forecast for the top drugs in the US from 2012-2022. - Analysis of the impact of key events as well the drivers and restraints affecting the US Hemophilia A and B market. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Disease Management 5 Competitive Assessment 5.1 Overview 5.2 Strategic Competitive Assessment 5.3 Product Profiles - Major Brands, Hemophilia A 5.4 Product Profiles - Hemophilia B 5.5 Product Profiles - Hemophilia A and B with Inhibitors 6 Opportunity and Unmet Need 7 Pipeline Assessment 7.1 Overview 7.2 Promising Drugs in Clinical Development - Hemophilia A 7.3 Promising Drugs in Clinical Development - Hemophilia B 7.4 Promising Drugs in Clinical Development - Hemophilia A and B Patients with Inhibitors 8 Market Outlook 9 Appendix For more information visit http://www.researchandmarkets.com/research/jv...harmapoint

Whitebox Advisors Adds Jon Olstein in Strategic Relationships Role
PR Newswire - Thu Jan 23, 1:00PM CST
Today, Whitebox Advisors, an asset management company based in Minneapolis with over $3 billion in AUM (12/31/2013), announced the addition of Jon Olstein as a managing director for strategic relationships based in the New York/Tri-state area.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 62

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 59

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print

Updated Category News Views 38

Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 43

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 36

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 56

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 36

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 70

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading

Top 5 Most Recently Viewed Articles

Flat Glass Market Growth and Future Trends Analysis

Updated Category News Views 256

Overview of the Flat Glass Market The flat glass market is on a remarkable trajectory, currently valued at USD 179.80 billion and poised to soar to USD 280.64 billion in the next few years, reflecting a compound annual growth rate (CAGR) of 8.0%. This growth is predominantly fueled by the booming construction and automotive sectors, coupled with a rising demand for...

Continue Reading
The Everglades Foundation Achieves Historic Fundraising Success

Updated Category News Views 435

Celebrating a Milestone for the Everglades Foundation The Everglades Foundation has achieved a monumental success, surpassing its fundraising target during its inaugural endowment campaign. With a remarkable outpouring of support, the Foundation raised $76 million in gifts and pledges from a dedicated group of 80 donors. This significant achievement ensures the long-term...

Continue Reading
Exploring Government's Generative AI Challenges and Solutions

Updated Category News Views 148

Understanding Government's Generative AI Landscape Government agencies are expressing considerable optimism about the potential of Generative AI (GenAI) technology, even as they face challenges in its implementation. Recent insights highlight that while budgeting for these innovations is high, the actual deployment of GenAI remains behind other industries. Survey findings...

Continue Reading
Key Information for DXC Technology Investors Ahead of Deadline

Updated Category News Views 71

Your Rights as a DXC Technology Investor If you're an investor in DXC Technology Company (NYSE: DXC), it’s important to understand your rights and the ongoing legal issues that could impact you. Bernstein Liebhard LLP, a well-respected law firm, wants to remind all DXC shareholders of a critical deadline that’s approaching. Who Needs to Be Concerned? Do you own shares...

Continue Reading
LM Funding America Inc. Reports Q3 2024 Results and Outlook

Updated Category News Views 115

Business Update and Financial Highlights LM Funding America, Inc. (NASDAQ: LMFA) has recently shared its financial results for the third quarter of 2024. This Tampa-based company focuses on cryptocurrency mining and technological finance solutions, showcasing significant strategic developments in its operations. Bitcoin Holdings and Revenue Performance As of September 30,...

Continue Reading